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Among human papillomavirus (HPV) types, clinical association with benign vs malignant lesions correlates with the ability
of the corresponding oncogenes to transform cells in vitro. However, even though HPV-11 is considered a low-risk type,
we have reported previously that the E5a oncogene of HPV-11gt is capable of transforming NIH 3T3 cells in culture. In this
study, we found that HPV-11gt E5a and E6 oncogenes have the ability to transform NIH 3T3 and the rat embryo fibroblast
line REF 52. Cells were transfected independently with expression plasmids containing the HPV-11gt E5a or E6 oncogenes
or both plasmids simultaneously to examine potential interactions. Cells containing these plasmids were phenotypically
transformed and had an accelerated doubling time, loss of contact inhibition of growth, and loss of anchorage dependence
for cell division. Independent cell lines containing the HPV-11gt E6 gene exhibited variable levels of phenotypic transformation
that correlated with the HPV-11gt E6 gene content. The degree of phenotypic transformation could be increased by elevating
the level of transcription of the E6 gene, indicating that there is a dose response effect for transformation in this system.
These results suggest that increased expression of E6 may be an important factor in malignant progression of naturally
occurring tumors. q 1996 Academic Press, Inc.
INTRODUCTION varying oncoprotein potency and the oncoprotein levels
attained in those particular cells.
Human papillomaviruses (HPVs) are transforming DNA The relative oncogenic potential of different HPV types
viruses that induce cellular proliferation conducive to the can be compared in vitro by testing the ability of the
development of epithelial tumors (Giri and Danos, 1986; respective DNAs to immortalize primary cell lines, or al-
Gissmann et al., 1983; Mounts et al., 1982; Schiffman et ternatively, to transform established rodent and human
al., 1993; zur Hausen, 1987). Although most of these tu- cells in culture after transfection. The immortalization
mors are benign, there is a spectrum of disease that assay primarily evaluates the role of HPV as an ‘‘initiator,’’
ranges from condylomas or benign warts to premalignant whereas the transformation assay evaluates its role as
and invasive carcinomas. HPV types that are usually as- a ‘‘promoter’’ of tumor induction. These types of assays
sociated with benign lesions, e.g., HPV-6 and -11, are have identified the oncogenes of HPV as E5, E6, and E7
considered low-risk, whereas other types, e.g., HPV-16 (Barbosa et al., 1991; Chen and Mounts, 1990; Halbert
and -18, are often referred to as high-risk, since they et al., 1992, 1991; Hiraiwa et al., 1993; Kiyono et al., 1992;
have been strongly associated with cancer in anogenital Storey and Banks, 1993). When studies have compared
and respiratory epithelia (de Villiers, 1989; Gissmann, the relative oncogenic potential among the oncogenes
1992; Kulski et al., 1990; Lancaster and Jensen, 1978; Wu obtained from high- vs low-risk types, the former have
et al., 1993). It is important to perform studies in vitro usually been stronger in vitro (Schmitt et al., 1994). For
that allow comparative analyses of high- vs low-risk HPV example, the E7 gene of HPV-16 or -18 is sufficient to
types as a means to identify differences that may uncover immortalize primary human epithelial cells (Halbert et al.,
critical elements required for HPV oncogenesis. As it is 1991), while HPV-6 E7 is not (Halbert et al., 1992). This
currently understood, the process of HPV oncogenesis finding has also been observed in the transformation
is complex and results primarily from the combined ef- assay, and the early region genes of high-risk types have
fects of oncoprotein function and levels of expression been able to cooperate with other oncogenes, such as
(Barbosa et al., 1991; Shah and Howley, 1990). Thus, the activated ras, in the transformation of rodent cells, while
functional differences between low- and high-risk viruses early regions of low-risk types have not (Storey and
that infect the same types of epithelia may result from Banks, 1993). In a transformation assay of human embry-
onic fibroblasts with HPV-16 early genes, both E6 and
E7 were found to be necessary (Storey et al., 1990). Stud-1 To whom correspondence and reprint requests should be ad-
ies have shown that a limited transforming activity candressed. Fax: (410) 955-0105. E-mail: pmounts@welchlink.welch.
jhu.edu. be measured for the early regions of HPV-6 and HPV-
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11 if expression is regulated by heterologous promoters contains the SV40 splice and polyadenylation signals
downstream of the cloning site.(Storey et al., 1988). In our laboratory, the transforming
activity of the E5a gene from an independent isolate of
Polymerase chain reaction (PCR) amplificationHPV-11 (HPV-11gt) has also been identified using NIH
3T3 and C127 cells (Chen and Mounts, 1990). We are To construct the plasmid pMT-E6.neo, the HPV-11gt
E6 was first amplified with ampliTaq DNA polymeraseinterested in studying the transforming potential of onco-
proteins from HPV-11 as well as possible interactions (Perkin–Elmer–Cetus, Norwalk, CT) using the plasmid
pHP-11gt containing the entire HPV11gt genome (Met-between them in order to identify differences relative to
high-risk types that may help with our understanding of calfe et al., 1989) as the template. The 5* end primer 5*-
ACGAAGCTTTATGGAAAGTAAAGATGCCT-3* and the 3*HPV oncogenesis.
The E6 gene encodes a protein that is approximately end primer 5*-AGTTCTAGATCCTTTAGGGTAACAAGTCT-3*
contain base mismatches (underlined) in positions 5, 8150 amino acids long. This protein contains four Cys-X-
X-Cys repeats, which are highly conserved in position and 4, 8, respectively. These mutations were introduced
to generate a HindIII site in the 5* end primer and a XbaIand number throughout the different oncogenic types
and which are characteristic of the zinc finger domains site in the 3* end primer as highlighted in bold. The
resulting 476-bp product containing the 453-bp E6 geneof some DNA binding proteins (Berg, 1986). HPV-18 E6
binds to zinc in vitro (Grossman and Laimins, 1989) and plus the restriction sites was then digested with HindIII
and XbaI for cloning. The same strategy was used toHPV-16 E6 has transcriptional trans-activating capabili-
ties (Sedman et al., 1991). Another function of E6 is the clone the E6 PCR product into the vector pGEM 2 (Pro-
mega, Madison WI), which contains flanking promotersbinding of the tumor-suppressor protein p53 in a complex
that results in the accelerated degradation of this factor for T7 or SP6 RNA polymerases, and into pBluescript II
SK (Stratagene, La Jolla, CA), which contains promotersthrough the ubiquitin-dependent proteolysis system
(Crook et al., 1991). The association of E6 with p53 is for T3 and T7 RNA polymerases. Successful cloning was
detected by analysis of restriction enzyme digests andmediated by an additional cellular factor designated E6-
AP, for E6-associated protein (Huibregtse et al., 1991). was verified through DNA sequencing (Sanger and Coul-
son, 1975), using a commercially available sequencingHowever, the ability of the E6 proteins of viruses of differ-
ent oncogenic potential to bind to p53 seems to vary kit (USBC, Cleveland, OH). Oligonucleotides used as
primers were synthesized by the Johns Hopkins Biopoly-(Werness et al., 1990; Farthing and Vousden, 1994).
In this study, we report that the HPV-11gt E6 gene is mers Laboratory.
able to transform NIH 3T3 and REF 52 cells (rat embryo
Cell culture and DNA transfectionfibroblasts) in culture. The transfected cells presented
varying degrees of transformation. We determined the NIH 3T3 cells were kept as monolayer cultures in Ea-
gle Minimal Essential Medium (MEM; GIBCO Labora-E6 gene content in cells with different phenotypes, and
we also investigated the effect of increasing transcription tories, Grand Island, N.Y.), with 10% calf serum (Hyclone,
Logan, UT). REF 52 clone 6 cells (Logan et al., 1981)of this gene by making use of an inducible promoter,
the mouse metallothionein I promoter. Our results are were obtained from Keith Peden (CBER, FDA) and were
grown as monolayer cultures in MEM, but were supple-consistent with the hypothesis that the degree of pheno-
typic transformation of cells transfected with the HPV- mented with 5% fetal bovine serum (Hyclone). NIH 3T3
cells were transfected with 2 mg of plasmid DNA using11gt E6 oncogene is related to E6 expression determined
by the copy number of the E6 gene and by the level of the Transfinity calcium phosphate precipitation kit (BRL
Laboratories; Gaithersburg, MD), selected in mediumtranscription.
containing G418, and scored for transformation as pub-
lished (Chen and Mounts, 1990). REF 52 cells wereMATERIALS AND METHODS
transfected with 3 mg of DNA using the Lipofectamine
Plasmid constructions
reagent (BRL Laboratories). The plasmid pMT-E5ab.neo
(Chen and Mounts, 1990) was used as a positive controlThe expression vector pMT.neo.1 (Peden et al., 1989)
was employed for cloning the HPV-11gt E6 gene. This for transformation.
recombinant vector carries resistance to the aminoglyco-
Establishment of cell linesside antibiotic G418 under the control of the herpesvirus
thymidine kinase promoter and allows selection of eu- Individual G418-resistant (G418r) colonies were picked
using a sterile cotton applicator pre-wet with a solutionkaryotic transfectants. The vector also confers resistance
to ampicillin for selection in bacteria. In addition, this containing 0.1% Trypsin in PBS and expanded in 24-well
plates.vector contains the mouse metallothionein type I pro-
moter immediately upstream of the cloning site. This pro-
Growth curve and anchorage independence assaymoter offers the advantage that it may be induced to
increase the levels of transcription with heavy metals The doubling times, saturation densities, and colony
formation in suspension were determined as describedsuch as zinc (Peden et al., 1989). The plasmid pMT.neo.1
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TABLE 2previously (Chen and Mounts, 1990), except that 2 to 4 1
103 cells were plated in semisolid medium. Experiments Drug Resistance and Focus Formation of Transfected REF 52 Cells
using induction with zinc were performed at 25, 50, and
Number of Number of75 mM zinc sulfate concentrations in the medium.
Plasmid G418-resistant transformed foci
transfected colonies (%)Statistical analysis
Mock 0 0 (0)For comparisons between means, a double-tailed Stu-
pMT.neo.1 185 15 (8)dent t test was employed (Sort, 1990). For comparisons
pMT-E6.neo 299 163 (55)
between percentage growth in semisolid medium, the pMT-E5ab.neo 259 146 (56)
difference between the cells that were transfected with
HPV sequences versus the control was tested using the
Kruskal–Wallis test, H  30.631, DF  5 (Sort, 1990). from total RNA was done using an Oligotex Direct kit
Comparisons among all the percentages were done us- (Qiagen, Chatsworth, CA).
ing the Boferroni-adjusted Mann–Whitney, d  0.10/15
RESULTS 0.0067 (Sort, 1990).
Sequence of HPV-11 E6
Southern hybridization
The nucleotide sequence obtained for the E6 gene
from the HPV-11gt genome that was molecularly clonedTotal cellular DNA was extracted from the cells as
published (Mounts and Kelly, 1984). Twenty micro- from a condyloma acuminatum of the cervix (Metcalfe et
al., 1989) revealed an identical length to the prototypegrams of DNA per sample were digested with EcoRI
and size fractionated by 1% agarose electrophoresis HPV-11 (Dartmann et al., 1986). Although four base
changes were identified, A to G, T to C, C to T, and Tand transferred onto nitrocellulose filters, 0.45 mm pore
size (Schleicher & Schuell, Keene, NH) as described to C at positions 132, 137, 380, and 402 relative to the
prototype, only the first one resulted in a change at posi-previously (Mounts and Kelly, 1984). Hybridization was
performed using a riboprobe labeled with [a-32P]CTP tion 12, from a threonine to an alanine, in the 151 amino
acids.by in vitro transcription with SP6 RNA polymerase (Pro-
mega) using the plasmid pGem2.HPV-11gtE6 as tem-
Focus forming activity of E6 in NIH 3T3 and REF-52plate. Filters were washed at high stringency condi-
cellstions. Autoradiographs were obtained using Kodak
Foci were scored by microscopic examination on theXAR X-ray film (Eastman Kodak, Rochester, NY) with
basis of morphological transformation, which includedintensification at 0707.
rounding, smaller size, higher refringency, and growth in
Northern hybridization multiple layers. NIH 3T3 cells transfected with E5a-b
were able to form foci in a high percentage of the colo-
Cells were plated in medium without additional zinc. nies, as published (Chen and Mounts, 1990), and served
Twenty-four hours later, zinc sulfate was added to half as our positive control for transformation. Cells that were
of the dishes to achieve a final concentration of 50 mM transfected with E6 were also able to form foci as pre-
and grown for 24 hr more. Total RNA was extracted by the sented in Table 1. In two independent experiments, NIH
guanidinium thiocyanate-cesium chloride centrifugation 3T3 cells that were transfected with pMT-E6.neo grew
method for Northern analysis as published previously transformed colonies in a higher percentage (85 and
(Ward and Mounts, 1988). Purification of poly(A)/ RNA 42%) than cells that were transfected with the pMT.neo.1
vector alone (15 and 4.5%). There were more transformed
colonies when plasmids containing E5a and E6 wereTABLE 1
transfected in combination. As expected, no G418r colo-
Drug Resistance and Focus Formation nies were obtained from mock transfection without
of Transfected NIH 3T3 Cells
pMT.neo.1 plasmid DNA. Similar results were obtained
in a different cell line, rat embryo fibroblasts, REF 52, inNumber of Number of
G418-resistant transformed foci which there was also a higher percentage formation of
colonies (%) transformed colonies in cells transfected with pMT-
E6.neo (55%) or pMT-E5ab.neo (51%) than in cells
Plasmid transfected Expt. 1 Expt. 2 Expt. 1 Expt. 2
transfected with pMT.neo.1 (8%) (Table 2).
Mock 0 0 0 (0) 0 (0)
Phenotype of NIH 3T3 cells transfected with HPV-11pMT.neo. 1 68 22 10 (15) 1 (4.5)
genespMT-E6.neo 68 12 41 (60) 6 (50)
pMT-E5ab.neo 39 52 33 (85) 22 (42) Individual G418r colonies were isolated as described
pMT-E6.neo / pMT-E5ab.neo 143 61 126 (88) 37 (61)
under Materials and Methods, and some of the resulting
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TABLE 3
Transformed Phenotype of NIH 3T3 Cells Transfected with E6 and E5a-b ORFs
Population doubling time (hours) Saturation density (Cells/cm2)
Plasmid
transfected Cell line 10% serum 2% serum 10% serum 2% serum
pMt.neo.1 N.neo.A6 50 149 1.8 1 104 7.0 1 103
pMT-E6.neo N.E6.B4 28 86 8.9 1 104 2.5 1 104
N.E6.B5 20 57 1.8 1 105 1.8 1 104
pMT-E5ab.neo N.E5.C5 22 96 5.4 1 104 2.1 1 104
lines were further characterized by determining the popu- taining the vector alone were not able to form colonies
in suspension. The manifestations of transformation ob-lation doubling time and saturation density in complete
growth medium as well as in medium reduced in serum tained in two cell lines that were transfected with both
E5a-b and E6 were not significantly different than those(Table 3). The population doubling time was reduced in
the cell lines that were transfected with plasmids con- obtained for E5a-b or E6 alone. As it had been apparent
when we measured the doubling times and saturationtaining the HPV-11gt genes as compared with a cell line
that was transfected with the vector alone. In complete densities for N.E6.B4 and N.E6.B5, there was also a dif-
ference in the level of transformation obtained in thesemedium supplemented with 10% calf serum, two cell
lines containing the HPV-11gt E6 gene, N.E6.B4 and cell lines in the anchorage-independence assay. Once
again, N.E6.B5 was more transformed with 57.4% of theN.E6.B5, had almost half the population doubling time of
N.neo.A6, a cell line that contained the vector sequences cells forming colonies as compared with 4.5% for
N.E6.B4. The phenotypic differences observed betweenalone. These differences were still apparent when the
growth curves were performed in medium with reduced independent cell lines that contain the plasmid pMT-
E6.neo led us to hypothesize that these might result fromserum concentration. The E5a-b-containing cell line,
N.E5.C5, was comparable to the E6-containing lines in a difference in the genetic load of pMT-E6.neo, i.e., the
number of copies of this plasmid in each line.its growth rate. Similarly, cell lines expressing E5a-b and
E6 were able to grow to a higher density than N.neo.A6
Southern analysiseven when grown in reduced serum concentration. Of
the two cell lines containing the HPV-11gt E6 gene, it Genomic DNA was extracted from some of the trans-
seems that N.E6.B5 grows faster than N.E6.B4. It is also formed cell lines for analysis by Southern hybridization
apparent that it achieves a higher saturation density than to corroborate the presence of the E5a-b and the E6
N.E6.B4 in complete medium, but not in medium with a genes in the corresponding cells (Fig. 1A). Genomic DNA
reduced concentration of serum. was digested with EcoRI, since this would release the
The ability of these lines to achieve anchorage-inde- E6 gene contained within a 3.3-kb fragment of the plas-
pendent growth was examined by culture in soft agarose mid pMT-E6.neo and would allow comparison of the rela-
(Table 4). Cells containing plasmids with the E5a-b and tive amounts of this gene in the two E6-transformed cell
E6 genes, alone or in combination, were able to form lines. For the standards, genomic DNA was extracted
colonies in suspension and are therefore considered from untransfected NIH 3T3 cells and mixed with differ-
transformed under this assay. In contrast, cells con- ent amounts of the pMT-E6.neo plasmid and digested in
parallel with EcoRI. The E6 riboprobe hybridized specifi-
cally to the expected 3.3-kb band in the standards asTABLE 4
shown in lanes 6–8. The corresponding band was visible
Anchorage Independence Assay for NIH 3T3 Cells Transfected
in lanes containing DNA from the E6-containing cell lineswith E6 or E5a-b ORFs
N.E6.B5 and N.E6.B4, lanes 1 and 2, respectively. This
Plasmid Percentage colonies band was absent in lanes containing DNA from cell lines
transfected Cell line Mean* ({ SE, n) N.E5.C5 (lane 3), N.neo.A6 (lane 4), and untransfected
NIH 3T3 cells (lane 5). Some background hybridization
pMT.neo.1 N.neo.A6 0.0a ({ 0.0, 7)
was seen at a higher molecular weight even in the nega-pMT-E6.neo N.E6.B4 4.5b ({ 0.6, 4)
tive controls. When comparing N.E6.B5 vs N.E6.B4, theN.E6.B5 57.4c ({ 2.6, 8)
pMT-E5ab.neo N.E5.C5 76.2d ({ 5.1, 12) E6 gene hybridization signal observed in the autoradiog-
pMT-E5ab.neo / N.E5E6.A2 73.0d ({ 1.5, 8) raphy was approximately 10-fold higher for N.E6.B5,
pMT-E6.neo N.E5E6.D3 59.5c ({ 0.9, 4) which exhibits a higher level of transformation than
N.E6.B4. This indicates a correlation between gene dos-Note. *Means identified by different superscript letters are statisti-
age and phenotypic transformation and suggests the hy-cally different from other letter designations. SE, standard error; n,
number of dishes scored. pothesis that higher levels of E6 lead to a more trans-
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or 75 mM. There was an increased number and size of
colonies in three of four cell lines containing pMT-E6.neo
when grown in the presence of zinc (Fig. 2). There were
no statistically significant differences among the number of
colonies obtained with the three zinc concentrations, and
therefore the data were compounded for further analysis.
The increase in anchorage-independent growth of cells in
the presence of zinc was statistically significant for the
cell lines N.E6.B4, N.E6.B6, and N.E6.B7 (Fig. 3). Relative
increments in transformation were larger in cells with lower
basal transformation than in cells that were already more
transformed. For example, N.E6.B7 formed colonies in only
14% of the cells without zinc, and this number was in-
creased to 38.2% when zinc was added to the medium. For
N.E6.B4 the increase was from 24% without zinc to 41.8%
with zinc, and for N.E6.B6 from 36% without zinc to 45%
with zinc. There was no significant difference in percentage
growth in N.E6.B5 when cultured with zinc (59.3%) vs with-
out zinc (55.5%). However, this cell line exhibited the highest
baseline growth.
FIG. 1. Detection of HPV-11gt E6 sequences in genomic DNA ex- Northern analysistracted from transformed cells lines. (A) Twenty micrograms of genomic
DNA from cell lines N.E6.B5 (lane 1), N.E6.B4 (lane 2), N.E5.C5 (lane In order to confirm that the addition of zinc to the
3), N.neo.A6 (lane 4) were digested with EcoRI, size fractionated in a
medium is increasing the levels of transcription of the1% agarose gel, and analyzed by Southern transfer and hybridization
E6 gene, the level of E6 mRNA in two cell lines withwith a 32P-labeled riboprobe containing the HPV-11gt E6 sequence. As
a negative control, NIH 3T3 genomic DNA was treated in parallel (lane different transformed phenotypes, N.E6.B4 and N.E6.B5,
5). Purified pMT-E6.neo plasmid was added to NIH 3T3 DNA in the which were grown in the presence or absence of zinc,
amounts of 4 pg (lane 6), 40 pg (lane 7), and 400 pg (lane 8), as was examined using Northern hybridization. Ethidium
standards. The arrow points to the expected 3.3-kb band. Bands in
bromide staining of the agarose gel prior to the transferother positions indicate integrations that occurred within the 3.3-kb
shows comparable amounts of RNA loaded for eachfragment. A 1-kb ladder (BRL) was used as size markers (SM). (B) A
duplicate filter was hybridized with a 32P-labeled riboprobe containing sample (Fig. 4A). The autoradiogram obtained after hy-
the sequence of the mouse b-actin gene. bridization with the E6 riboprobe shows the presence of
E6 message in RNA from N.E6.B5 cells that had been
cultured in the presence of zinc (Fig. 4B, lane 5) but notformed phenotype. A filter loaded in duplicate for each
in uninduced cells (lane 4). Duplicate filters showed thecell line was hybridized with a riboprobe specific for the
presence of E6 message in uninduced N.E6.B5 only aftermouse b-actin gene (Fig. 1B) and shows that small differ-
prolonged exposure (data not shown). The E6 messageences in the amounts of DNA loaded did not account for
was not detectable in N.E6.B4 cells (lanes 2 and 3). Forthe differences in hybridization using the E6 riboprobe.
these cells, Northern analysis of poly(A)/ RNA confirmedThe specificity of the DNA present in the cell lines was
the presence of the E6 message after induction with zincconfirmed by hybridizing a duplicate filter with a ribo-
(Fig. 4C, lane 3), but not in the uninduced state (lane 2).probe complementary to the E5a-b genes, where hybrid-
Total and poly(A)/ RNA from N.neo.A6 cells were in-ization was only detected in DNA from N.E5.C5 (data not
cluded as negative controls (lane 1).shown).
Induction of the transcription of E6 DISCUSSION
Since a difference in the transformed phenotype of two The comparisons of the relative potency of the proteins
cell lines containing different amounts of the E6 gene was of HPVs with different oncogenic potential as well as
apparent, we were interested in testing the hypothesis that their relative levels of expression have been important
this correlated with levels of E6 transcription. Therefore, areas in the research of HPV oncogenesis (Barbosa et
we examined if increasing the level of E6 would result in al., 1991; de Villiers, 1989; Gage et al., 1990; Hiraiwa et
increased transformation. Since the E6 gene is located al., 1993; Iwasaka et al., 1993; Kiyono et al., 1992). Our
downstream of a metallothionein promoter, the level of tran- study is the first to obtain transformation of NIH 3T3 and
scription can be increased by adding zinc to the medium. REF 52 cells upon transfection with a plasmid encoding
Four cell lines that had been transfected with pMT-E6.neo the HPV-11gt E6 and it is also the first to show transfor-
were cultured in soft agarose in the presence or absence mation of rat embryo fibroblasts with HPV-11gt E5a-b
genes. Other systems using different methodologies andof zinc sulfate added to the final concentrations of 25, 50,
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FIG. 2. Increase in anchorage independence of pMT.E6.neo containing NIH 3T3 cells in medium added with zinc. N.E6.B4 cells were plated in
MEM medium containing 0.5% agarose (A) vs identical medium with zinc sulfate added to 75 mM (B). Photomicrographs of representative colonies
were taken on Day 22 (2001).
cell types have not succeeded in identifying a trans- reducing the background of nontransformed colonies
present in a more heterogeneous population. The spec-forming potential in the early region of HPV-11. In one
trum of transformation presented by different cell linesstudy, the plasmid employed contained the entire HPV-
is probably determined by the number of plasmids that11 genome placed downstream of a Moloney Murine
are integrated into the particular genomes and the indi-Leukemia Virus LTR, and it was unable to transform pri-
vidual sites of integration.mary rat kidney epithelial cells (BRK) (Storey et al., 1988).
In other studies, the oncogenic potential of HPV-6b E6Another study did not obtain a transforming activity of
was tested in NIH 3T3 cells and no transformation wasHPV-11 E6 in 3Y1 rat fibroblasts (Hiraiwa et al., 1993).
obtained (Barbosa et al., 1991). A direct comparison withSome of these earlier studies have shown an overall low
this experimental system becomes more difficult, sincelevel of colony formation in suspension by pooling the
the amino acid sequence of HPV-6b E6 (Schwarz et al.,transfected cells and plating them in soft agar medium.
1983) has thirty substitutions compared to the sequenceOur strategy involved preselecting and establishing indi-
of HPV-11gt that we used in our experiments. Relativevidual cell lines with varying morphologies obtained from
to the prototype HPV-11 E6, which was molecularlyG418r colonies. Each line presented variable levels of
cloned from a respiratory tract papilloma (Gissmann etcolony formation in suspension. This improves the scor-
ing of cell lines with a more transformed phenotype by al., 1982), there is only one amino acid change in the
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formed, it appears that the transformation process is sat-
urable.
It is presently proposed that one potential mechanism
for the oncogenic potential of the E6 gene is exerted
through the binding of the tumor suppressor p53, which
is mediated by E6-AP (E6 accessory protein) (Huibregtse
et al., 1991). This association leads to an accelerated
degradation of p53 through the ubiquitin-dependent pro-
teolysis system (Scheffner et al., 1990). Furthermore, the
regions within E6 that are responsible for binding are
different from those involved in the degradation of p53,
and there appears to be a correlation between the onco-
genic HPV type and the level of induced degradation of
p53 in vitro (Crook et al., 1991). In that regard, HPV-11
E6 has been able to bind to p53 in vitro, but it does not
function in accelerating the degradation of p53 (Crook et
al., 1991). The region in E6 involved in p53 degradation
has been localized to the N terminal half of the protein,
and it is in this half that the amino acid change in HPV-
11gt E6 was identified. However, p53-independent alter-
natives are also being investigated (Sedman et al., 1992;
Chen et al., 1995).
It will also be important to test functional interactionsFIG. 3. Relative increments in percentage colony formation in sus-
pension for cell lines containing the plasmid pMT-E6.neo after induction of this protein with other HPV proteins such as E7, since
with zinc. The cell line N.neo.A6 was included as a negative control. in many systems, high-risk type E6 genes but not low-
SE, standard error. risk types have been able to have a cooperative effect
with E7 (Sedman et al., 1991). In our studies, we also
sequence of HPV-11gt E6, which we are studying. The examined the phenotype of cells transformed with both
E6 gene in the prototype HPV-11 was not able to comple- HPV-11 E6 and E5a-b and did not find a level of transfor-
ment E7 in the immortalization of human foreskin kera- mation that was significantly higher than that of cells
tinocytes but was not evaluated for its ability to transform transfected with E5a-b alone. These results suggest that
NIH 3T3 cells in these studies (Barbosa et al., 1991). the interaction between these two gene products is not
We have used an inducible promoter and identified a necessary for the induction of a transformed phenotype,
correlation between the levels of transcription of the E6 but it does not rule out the possibility that an interaction
gene and the transformed phenotype, supporting the hy- between these two oncogenes expressed jointly at lower
pothesis that transformation by HPV11gt-E6 is dose de- levels may have a synergistic effect. To test this hypothe-
pendent. Since the increase in transformation upon in- sis it would be appropriate to employ cells that are more
duction with zinc was lower in cells that were already resistant to oncogenes when transfected individually,
such as primary human epithelial cells.more transformed than in those that were less trans-
FIG. 4. Analysis of HPV-11gt E6 mRNA in transformed cell lines. Ten micrograms of total RNA were size fractionated in a 1.6% agarose gel
containing 2.2 M formaldehyde and analyzed by Northern transfer and hybridization with an HPV-11gt E6 antisense riboprobe labeled with 32P. (A)
Photograph of the agarose gel stained with ethidium bromide showing 18 S and 28 S ribosomal RNA. N.E6.B4 (lanes 2 and 3) and N.E6.B5 (lanes
4 and 5) were grown in parallel in MEM (lanes 2 and 4) vs medium with zinc added to 50 mM (lanes 3 and 5). N.neo.A6 was included as a negative
control (lane 1). A 1-kb ladder (BRL) was used as size markers (M). (B) Autoradiogram obtained after hybridization of the nitrocellulose filter. The
arrow points to the predicted position of the E6 message visible in lane 5. There was cross-hybridization of the probe with ribosomal RNA,
predominantly 28 S, which served as an internal standard. The radioactive spot in the middle of lane 5 was absent in duplicate filters. (C)
Autoradiogram obtained after Northern analysis of poly(A)/ RNA obtained from N.neo.A6 (lane 1) and N.E6.B4 grown in MEM (lane 2) vs medium
with zinc (lane 3). The arrow points to the E6 message.
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the oncogenic HPV-16 differ in retinoblastoma protein binding andThe inducibility of this expression system makes it
other properties. J. Virol. 64, 724–730.especially valuable since the effects of over-expression
Giri, I., and Danos, O. (1986). Papillomavirus genomes: From sequenceof E6 may be studied in vivo. Doebritz et al. (1994) found data to biological properties. Trends Genet. September, 227–242.
that the transformed phenotype of a cervical carcinoma Gissmann, L. (1992). Papillomaviruses and human oncogenesis. Curr.
cell line, SW 756, also correlates with the level of expres- Opinion Genet. Dev. 2, 97–102.
Gissmann, L., Wolnik, L., Ikenberg, H., Koldovsky, U., Schnu¨rch, H. G.,sion of HPV-18 E6 and E7. The demonstration that the
and zur Hausen, H. (1983). Human papillomaviruses types 6 and 11phenotypic transformation of cells transfected with the
DNA sequences in genital and laryngeal papillomas and in someHPV-11gt E6 oncogene is related to the level of E6 ex-
cervical cancers. Proc. Natl. Acad. Sci. USA 80, 560–563.
pression suggests that the identification of low-risk HPVs Gissmann, L., Diehl, V., Schultz-Coulon, H. J., and zur Hausen, H. (1982).
in malignant tumors (Byrne et al., 1987; Kulski et al., 1990; Molecular cloning and characterization of human papillomavirus
DNA derived from a laryngeal papilloma. J. Virol. 44, 393–400.McGlennen et al., 1992; Sutton et al., 1987; Wu and
Grossman, S. R., and Laimins, L. A. (1989). E6 protein of human papillo-Mounts, 1989) may result from an elevated level of E6.
mavirus type 18 binds zinc. Oncogene 4, 1089–1093.Such an elevation in E6 levels may arise by an increase
Halbert, C. L., Demers, G. W., and Galloway, D. A. (1992). The E6 andin the copy number of the viral genome through en-
E7 genes of human papillomavirus type 6 have weak immortalizing
hanced DNA replication or by an increase in the tran- activity in human epithelial cells. J. Virol. 66, 2225–2234.
scription of E6, and this may be an important factor in Halbert, C. L., Demers, G. W., and Galloway, D. (1991). The E7 gene of
human papillomavirus type 16 is sufficient for immortalization of hu-malignant progression of naturally occurring tumors.
man epithelial cells. J. Virol. 65, 473–478.
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